Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$828K Buy
6,447
+2
+0% +$234 0.35% 70
2026
Q1
$775K Sell
6,445
-13
-0.2% -$1.5K 0.36% 70
2025
Q4
$680K Sell
6,458
-567
-8% -$53.2K 0.31% 72
2025
Q3
$590K Sell
7,025
-4
-0.1% -$329 0.27% 77
2025
Q2
$556K Sell
7,029
-114
-2% -$9.06K 0.28% 75
2025
Q1
$641K Sell
7,143
-1,325
-16% -$124K 0.37% 68
2024
Q4
$842K Sell
8,468
-1,559
-16% -$161K 0.48% 52
2024
Q3
$1.14M Sell
10,027
-1,122
-10% -$133K 0.69% 37
2024
Q2
$1.38M Buy
11,149
+2,599
+30% +$335K 0.94% 22
2024
Q1
$1.13M Buy
8,550
+226
+3% +$27.9K 0.85% 24
2023
Q4
$907K Buy
8,324
+204
+3% +$21.2K 0.74% 29
2023
Q3
$836K Buy
8,120
+3
+0% +$323 0.76% 28
2023
Q2
$937K Buy
8,117
+166
+2% +$18.8K 0.87% 27
2023
Q1
$846K Sell
7,951
-153
-2% -$16.5K 0.85% 28
2022
Q4
$749K Buy
+8,104
New +$828K 0.84% 33

Other funds holding MRK

Core Wealth Partners's MRK Position: Q2 2026 in Review

Core Wealth Partners increased its Merck (MRK) stake by 0.03% in Q2 2026, buying an estimated $234 and bringing the position to 6,447 shares worth $828K. The position accounts for 0.35% of the portfolio, ranked #70.

Core Wealth Partners first reported a position in MRK in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.38M in Q2 2024. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Core Wealth Partners held 6,447 shares of Merck worth $828K as of Q2 2026.
  • Core Wealth Partners bought 2 Merck shares in Q2 2026, an estimated $234.
  • Merck made up 0.35% of Core Wealth Partners's portfolio in Q2 2026, its #70 holding.
  • Core Wealth Partners first reported a position in Merck in Q4 2022 and has held it in 15 quarters since.
  • Core Wealth Partners's Merck position peaked at $1.38M in Q2 2024.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Core Wealth Partners's 13F filing for Q2 2026, filed 17 Jul 2026.